Recent Breakthroughs In Understanding The Biology Of Alzheimer’sShow: Ask Dr. DeSilva
Guest(s)
Dora Games, Ph.D.
Topic
Alzheimer's Disease
Topic Info
Recent news about Alzheimer’s disease has ranged from hopeful to discouraging. There is a need for greater awareness and research funds. While brain scans and other tests are helping researchers detect disease symptoms earlier, recent failed drug trials have renewed the debate over what causes this devastating disease.
Dr. Dora Games joins the show with some updated info on recent breakthroughs in the understanding of the biology of Alzheimer's Disease.
Guest Info
Dr. Dora Games of Elan Pharmaceuticals has focused on the use of transgenic and other models of neurodegenerative diseases to test the efficacy of potential therapeutics. Over the past several years, her work has focused on the characterization of various immunotherapeutic approaches for Alzheimer’s disease, some which are currently in clinical trials. These studies enabled outcome measures in preclinical models that differentiate both the efficacy and potential clinical applications of these immunotherapies. Currently she is Vice President of Pharmacology at Neotope Biosciences, a division of Elan Pharmaceuticals.
Host
Dr. Derrick DeSilva
Show Date
2010-10-04
Submit reviewRecommendPrint
Rate this listing
0 vote
|
The information and opinions expressed herein and on the programs provide general information relating to health and are not intended to constitute advice or specific recommendations relating to any particular ailment, disease or condition. Listeners should not individually rely on the information given here and the information and program content is not a substitute for a consultation with a qualified medical doctor. We encourage you to make an appointment with your own doctor in order to resolve any of your health concerns.